In our study, we found that WFDC12 was up-regulated in AD patients and DNFB-induced AD mice models through public databases and related confirmatory experiments, and preliminarily clarified the clinical relevance of its expression with AD. This evidence concerns the gene WFDC12 and Alzheimer disease.